Suppr超能文献

链阳菌素达福普汀和奎奴普汀的协同作用诱导核糖体肽基转移酶中心发生改变。

Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin.

作者信息

Harms Jörg M, Schlünzen Frank, Fucini Paola, Bartels Heike, Yonath Ada

机构信息

Max-Planck Research Unit for Ribosomal Structure, 22603 Hamburg, Germany.

出版信息

BMC Biol. 2004 Apr 1;2:4. doi: 10.1186/1741-7007-2-4.

Abstract

BACKGROUND

The bacterial ribosome is a primary target of several classes of antibiotics. Investigation of the structure of the ribosomal subunits in complex with different antibiotics can reveal the mode of inhibition of ribosomal protein synthesis. Analysis of the interactions between antibiotics and the ribosome permits investigation of the specific effect of modifications leading to antimicrobial resistances. Streptogramins are unique among the ribosome-targeting antibiotics because they consist of two components, streptogramins A and B, which act synergistically. Each compound alone exhibits a weak bacteriostatic activity, whereas the combination can act bactericidal. The streptogramins A display a prolonged activity that even persists after removal of the drug. However, the mode of activity of the streptogramins has not yet been fully elucidated, despite a plethora of biochemical and structural data.

RESULTS

The investigation of the crystal structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with the clinically relevant streptogramins quinupristin and dalfopristin reveals their unique inhibitory mechanism. Quinupristin, a streptogramin B compound, binds in the ribosomal exit tunnel in a similar manner and position as the macrolides, suggesting a similar inhibitory mechanism, namely blockage of the ribosomal tunnel. Dalfopristin, the corresponding streptogramin A compound, binds close to quinupristin directly within the peptidyl transferase centre affecting both A- and P-site occupation by tRNA molecules.

CONCLUSIONS

The crystal structure indicates that the synergistic effect derives from direct interaction between both compounds and shared contacts with a single nucleotide, A2062. Upon binding of the streptogramins, the peptidyl transferase centre undergoes a significant conformational transition, which leads to a stable, non-productive orientation of the universally conserved U2585. Mutations of this rRNA base are known to yield dominant lethal phenotypes. It seems, therefore, plausible to conclude that the conformational change within the peptidyl transferase centre is mainly responsible for the bactericidal activity of the streptogramins and the post-antibiotic inhibition of protein synthesis.

摘要

背景

细菌核糖体是几类抗生素的主要作用靶点。研究核糖体亚基与不同抗生素结合的结构能够揭示核糖体蛋白质合成的抑制模式。分析抗生素与核糖体之间的相互作用有助于研究导致抗菌耐药性的修饰的具体影响。链阳菌素在靶向核糖体的抗生素中独具特色,因为它们由链阳菌素A和B两个组分组成,二者协同发挥作用。每种化合物单独使用时表现出较弱的抑菌活性,而二者联合使用则具有杀菌作用。链阳菌素A显示出持久的活性,即使在去除药物后仍能持续存在。然而,尽管有大量的生化和结构数据,链阳菌素的作用模式尚未完全阐明。

结果

对来自耐辐射球菌的50S核糖体亚基与临床相关链阳菌素奎奴普丁和达福普汀结合的晶体结构进行研究,揭示了它们独特的抑制机制。奎奴普丁是一种链阳菌素B化合物,以与大环内酯类相似的方式和位置结合在核糖体出口通道中,提示存在相似的抑制机制,即阻断核糖体通道。达福普汀是相应的链阳菌素A化合物,直接在肽基转移酶中心靠近奎奴普丁的位置结合,影响tRNA分子对A位点和P位点的占据。

结论

晶体结构表明,协同效应源于两种化合物之间的直接相互作用以及与单个核苷酸A2062的共同接触。链阳菌素结合后,肽基转移酶中心发生显著的构象转变,导致普遍保守的U2585形成稳定的、无活性的取向。已知该rRNA碱基的突变会产生显性致死表型。因此,可以合理地得出结论,肽基转移酶中心内的构象变化主要负责链阳菌素的杀菌活性以及抗生素后对蛋白质合成的抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e1f/400760/0e349a377085/1741-7007-2-4-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验